+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

NGS-Based RNA-Sequencing: Global Strategic Business Report

  • PDF Icon

    Report

  • 196 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805270
Description Jump to:

Global NGS-Based RNA-Sequencing Market to Reach $8.6 Billion by 2030

The global market for NGS-Based RNA-Sequencing estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$8.6 Billion by 2030, growing at a CAGR of 20.2% over the analysis period 2022-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is projected to record a 20.7% CAGR and reach US$4.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sample Preparation segment is readjusted to a revised 17.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $579 Million, While China is Forecast to Grow at 18.9% CAGR

The NGS-Based RNA-Sequencing market in the U.S. is estimated at US$579 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 18.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.4% and 17.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.5% CAGR.

Select Competitors (Total 46 Featured) -

  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • RNA-Seq: An Introduction
  • A Prelude to NGS-based RNA-seq Market
  • North America: The Largest Market for NGS-based RNA-seq
  • NGS-based RNA-seq - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • NGS-based RNA-seq Market Drivers and Restraints
  • Recent Advances in RNA Sequence Analysis
  • Select Players of NGS-based RNA-seq Market
  • Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique
  • Application of RNA-Seq in Precision Medicine
  • Next Generation Sequencing in Cancer Research
  • Next Generation Sequencing for Transcriptomic Profiling
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Sequencing by Synthesis (SBS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Sequencing by Synthesis (SBS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Ion Semiconductor Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Ion Semiconductor Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Single-molecule Real-time (SMRT) Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World NGS-Based RNA-Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 14: World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 15: World 8-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Sequencing Platforms & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World 8-Year Perspective for Sequencing Platforms & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Data Analysis, Storage & Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 23: World 8-Year Perspective for Data Analysis, Storage & Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 25: World 8-Year Perspective for Research Centers & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 28: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 29: USA 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 30: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 31: USA 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: USA 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
CANADA
  • Table 34: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 35: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 36: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 37: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Canada 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
JAPAN
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 40: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 41: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 42: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 43: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 44: Japan Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Japan 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
CHINA
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 46: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 47: China 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 48: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 49: China 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 50: China Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: China 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
EUROPE
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 52: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 55: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 57: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 58: Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 59: Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
FRANCE
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 60: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 61: France 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: France 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 64: France Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 65: France 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
GERMANY
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 66: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 67: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 70: Germany Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 71: Germany 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
ITALY
  • Table 72: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 73: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 76: Italy Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 77: Italy 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
UNITED KINGDOM
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 78: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 79: UK 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: UK 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 82: UK Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 83: UK 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
REST OF EUROPE
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 85: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 88: Rest of Europe Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 89: Rest of Europe 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
ASIA-PACIFIC
  • NGS-Based RNA-Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 91: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 94: Asia-Pacific Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 95: Asia-Pacific 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
REST OF WORLD
  • Table 96: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Technology - Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 97: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by Technology - Percentage Breakdown of Value Sales for Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing and Nanopore Sequencing for the Years 2023 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by End-Use - Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 99: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers & Academic Institutes, Hospitals & Clinics, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • Table 100: Rest of World Recent Past, Current & Future Analysis for NGS-Based RNA-Sequencing by Product & Service - Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 101: Rest of World 8-Year Perspective for NGS-Based RNA-Sequencing by Product & Service - Percentage Breakdown of Value Sales for Sequencing Platforms & Consumables, Sample Preparation, Sequencing Services and Data Analysis, Storage & Management for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedApril 2024
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.6 Billion
Compound Annual Growth Rate20.0%
Regions CoveredGlobal

Related Topics

Related Reports

NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, Small RNA), End-User, Region - Global Forecast to 2027 - Product Image

NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, Small RNA), End-User, Region - Global Forecast to 2027

  • Report
  • 202 Pages
  • Global
From
Global NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Forecast 2024-2030 - Product Image

Global NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (DNA, Library Preparation, Quality Control), Technology, Application, End-User - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global NGS-Based RNA-Sequencing Market by Product & Services (Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services), Technology (Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis), Application, End-User - Forecast 2024-2030 - Product Image

Global NGS-Based RNA-Sequencing Market by Product & Services (Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services), Technology (Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis), Application, End-User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
NGS-Based RNA-Sequencing Global Market Report 2024 - Product Image

NGS-Based RNA-Sequencing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.